INNOVADERM CRO IS NOW INDERO.

Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

Multiple Authors

Multiple Authors

Author picture

Date: 2023-08-02

Authors: Melissa L. Johnson, James Strauss, Manish R. Patel, Edward B. Garon, Keith D. Eaton, Tavette Neskorik, Josée Morin, Richard Chao, Balazs Halmos

Category: Other

Conflict of interest statement: Conflicts of interest The full list is provided in Appendix S1 (see Supporting Information).


Read more on pubmed

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.